| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |